TETRAPHASE PHARMACEUTICALS INC: cashflow_operating
| Value | {"amount": -71265000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} |
|---|---|
| Period | 2017-01-01 – 2017-09-30 |
| Status | current |
| Entity | TETRAPHASE PHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:11:20.304535+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/f4c5f766-5b33-4c8d-b6b5-0fcefcbf5cba
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-18-028694 · Open the official SEC filing →Retrieved: 2026-08-19T13:11:20.304535+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001373707/cashflow-operating/2017-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/f4c5f766-5b33-4c8d-b6b5-0fcefcbf5cba
History
- supersedes {"amount": -71265000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "currency": "USD"} (evidence 0001564590-17-020834)